Standard
Reply to Methodological Approach to Mesalazine Treatment in Patients with Mild-to-moderate Ulcerative Colitis. / Pedersen, Natalia; Munkholm, Pia.
I:
Inflammatory Bowel Diseases, Bind 21, Nr. 8, 08.2015, s. E15-6.
Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt
Harvard
Pedersen, N
& Munkholm, P 2015, '
Reply to Methodological Approach to Mesalazine Treatment in Patients with Mild-to-moderate Ulcerative Colitis',
Inflammatory Bowel Diseases, bind 21, nr. 8, s. E15-6.
https://doi.org/10.1097/MIB.0000000000000484APA
Pedersen, N.
, & Munkholm, P. (2015).
Reply to Methodological Approach to Mesalazine Treatment in Patients with Mild-to-moderate Ulcerative Colitis.
Inflammatory Bowel Diseases,
21(8), E15-6.
https://doi.org/10.1097/MIB.0000000000000484Vancouver
Pedersen N
, Munkholm P.
Reply to Methodological Approach to Mesalazine Treatment in Patients with Mild-to-moderate Ulcerative Colitis.
Inflammatory Bowel Diseases. 2015 aug.;21(8):E15-6.
https://doi.org/10.1097/MIB.0000000000000484Author
Pedersen, Natalia ; Munkholm, Pia. / Reply to Methodological Approach to Mesalazine Treatment in Patients with Mild-to-moderate Ulcerative Colitis. I: Inflammatory Bowel Diseases. 2015 ; Bind 21, Nr. 8. s. E15-6.
Bibtex
@article{54a7283373044abea6f76d15ebc6b608,
title = "Reply to Methodological Approach to Mesalazine Treatment in Patients with Mild-to-moderate Ulcerative Colitis",
keywords = "Anti-Inflammatory Agents, Non-Steroidal, Colitis, Ulcerative, Female, Humans, Internet, Male, Mesalamine, Precision Medicine, Self Care, Telemedicine",
author = "Natalia Pedersen and Pia Munkholm",
year = "2015",
month = aug,
doi = "10.1097/MIB.0000000000000484",
language = "English",
volume = "21",
pages = "E15--6",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "Lippincott Williams & Wilkins",
number = "8",
}
RIS
TY - JOUR
T1 - Reply to Methodological Approach to Mesalazine Treatment in Patients with Mild-to-moderate Ulcerative Colitis
AU - Pedersen, Natalia
AU - Munkholm, Pia
PY - 2015/8
Y1 - 2015/8
KW - Anti-Inflammatory Agents, Non-Steroidal
KW - Colitis, Ulcerative
KW - Female
KW - Humans
KW - Internet
KW - Male
KW - Mesalamine
KW - Precision Medicine
KW - Self Care
KW - Telemedicine
U2 - 10.1097/MIB.0000000000000484
DO - 10.1097/MIB.0000000000000484
M3 - Letter
C2 - 26111214
VL - 21
SP - E15-6
JO - Inflammatory Bowel Diseases
JF - Inflammatory Bowel Diseases
SN - 1078-0998
IS - 8
ER -
